Do zopiclone, zolpidem and flunitrazepam have residual effects on simulated task of collision anticipation?

Journal of Psychopharmacology

Volumn 17, Issue 3, 2003, Pages 324-331

  Berthelon, C ^a   Bocca, M L ^b   Denise, P ^c   Pottier, A ^d  

^a Departement Mecanismes d'Accidents   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSITÉ DE CAEN   (France)

^d Laboratory of Driver Psychology   (France)

Author keywords

Anticipation of collision; Driving; Flunitrazepam; Residual effect; Zolpidem; Zopiclone

Indexed keywords

BENZODIAZEPINE; FLUNITRAZEPAM; HYPNOTIC AGENT; HYPNOTIC SEDATIVE AGENT; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; ZOLPIDEM; ZOPICLONE;

ADULT; ANTICIPATION; ARTICLE; ATTENTION; CAR DRIVING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRIVER; DRUG EFFECT; DRUG HALF LIFE; FEMALE; HALF LIFE TIME; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SIMULATION; TASK PERFORMANCE; TIME; TRAFFIC ACCIDENT; VISUAL INFORMATION;

ACCIDENTS, TRAFFIC; ADULT; ATTENTION; AUTOMOBILE DRIVING; FEMALE; FLUNITRAZEPAM; HALF-LIFE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PIPERAZINES; PYRIDINES; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS;

EID: 0141815719     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/02698811030173015     Document Type: Article

References (61)

1. Allain H, Patat A, Lieury A, Le Coz F, Janus C, Menard G, Gandon J M (1995) Comparative study of the effects of zopiclone (7.5 mg), zolpidem, flunitrazepam and a placebo on noctural cognitive performance in healthy subjects, in relation to pharmacokinetics. Eur Psychiatry 10(Suppl 3): 129S-135S
2. Allen D, Curren H V, Lader M (1991) The effects of repeated doses of clomipramine and alprazolam on physiological performance and cognitive functions in normal subjects. Eur J Clin Pharmacol 40: 355-362
3. Arditti J, Bourdon J H, David J M, Lanze L, Thirion X, Jouglard J (1993) Imprégnation en benzodiazépines de conducteurs impliqués dans des accidents de la circulation. La presse médicale 22: 765-766
4. Barbone F, MacMahon A, Davey P, Morris A, Reid I, MacDevitt D, MacDonald T (1998) Association of road-traffic accidents with benzodiazepine use. Lancet 352: 1331-1336
5. Benzodiazepines/Driving Collaborative Group (1993) Are benzodiazepines a risk factor for road accidents? Drug Alcohol Depend 33: 19-22
6. Berthelon C, Mestre D, Taramino R (1995) Anticipation visuelle de collisions en situations simulées: effets de l'expérience de la conduite. Le Travail Humain 58: 311-338
7. Berthelon C, Mestre D, Pottier A, Pons R (1998) Is visual Anticipation of Collision during self-motion related to perceptual style? Acta Psychologica 98: 1-16
8. Berthelon C, Mestre D, Nachtergaële C (1999) Road environment and visual anticipation of a collision during self-motion. In Gale A G (ed), Brown I D, Haslegrave C M, Taylor S P (co-eds), pp. 355-371. Vision in vehicle VII. Elsevier Science, Amsterdam
9. Billiard M, Besset M, de Lustrac C, Brissaud L (1987) Dose response effects of zopiclone on night sleep and daytime functionning. Sleep 10 (Suppl 1): 27-34
10. Blois R (1997) Effects des médicaments psychotropes sur la vigilance chez l'homme. Confrontations psychiatriques 38: 179-211
11. Blouin J, Vercher J-L, Gauthier G M, Labrousse L, Simoneau M (1999) Updating visual space when rotating the head during whole-body displacements. In Gale A G (ed), Brown I D, Haslegrave C M, Taylor S P (co-eds), pp. 329-344. Vision in vehicle VII. Elsevier Science, Amsterdam
12. Bocca M L (2000) Effets résiduels des hypnotiques sur la conduite automobile en situation simulée. Thèse de Sciences, Université Paris XI, Orsay
13. Bocca M L, Le Doze F, Etard O, Pottier M, L'Hoste J, Denise P (1999) Residual effects of zolpidem 10 mg and zopiclone 7.5 mg vs. flunitrazepam 1 mg and placebo on driving performance and ocular saccades. Psychopharmacology 143: 373-379
14. Bond A J, Lader M H (1975) Residual effects of flunitrazepam. Br J Clin Pharmacol 2: 143-150
15. Bonnet C (1986) Manuel pratique de psychophysique. Armand Colin, Paris
16. Borbely A A (1984) Ambulatory motor activity monitoring to study the time course of hypnotic action. Br J Clin Pharmacol 18 (Suppl 1): 83S-86S
17. Breckenridge R L, Dodd M O (1991) Locus of control and alcohol placebo effects on performance in a driving simulator. Perceptual Motor Skills 72: 751-756
18. Broadhurst A, Cushnaghan R C (1987) Residual effects of zopiclone (Imovane). Sleep 10: 48-53
19. Brookhuis K (1998) How to measure driving ability under the influence of alcohol and drugs, and why. Hum Psychopharmacol Clin Exp 13: S64-S69
20. Cavallo V, Mestre D, Berthelon C (1997) Time-to-collision judgments: visual and spatio-temporal factors. In Rothengatter J A, Carbonell Vaya E J (eds), Traffic and transport psychology: theory and application, pp. 97-112. Elsevier Science, Amsterdam
21. De Gier J J (1995) Estimation of psychotropic drugs secondary effects on the vigilance. In Vallet M, Kardi S (eds), Vigilance et transport. Aspects fondamentaux, dégradation et prévention, pp. 101-110. Presses Universitaires de Lyon, Lyon
22. Etard O, Denise P, Pottier M, Gauriat P, Durand C, L'hoste J (1995) Effets résiduels et interaction avec l'alcool d'une prise unique de 10 mg de zolpidem évalués sur simulateur de conduite. In Vallet M, Kardi S (eds), Vigilance et transport. Aspects fondamentaux, dégradation et prévention, pp. 163-171. Presses Universitaires de Lyon, Lyon
23. Fairweather D B, Kerr J S, Hindmarch I (1992) The effects of accute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognitive function in elderly volunteers. Eur J Clin Pharmacol 43: 597-601
24. Fernandez C, Martin C, Gimenez F, Farinotti R (1995) Clinical pharmacokinetics of zopiclone. Clin Pharmacokinet 29: 431-441
25. Fillmore M T, Vogel-Sprott M (1995) Expectancies about alcohol-induced motor impairment predict individual differences in responses to alcohol and placebo. J Studies Alcohol 56: 90-98
26. Girre G, Facy F, Lagier G, Dally S (1988) Présence de benzodiazépines dans le sérum de sujets accidentés. La Presse Médicale 22: 1135-1138
27. Hajak G, Clarenbach P, Fischer W, Haase W, Rüther E (1994) Zopiclone improves sleep quality and daytime well-being in insomniac patients: comparison with triazolam, flunitrazepam and placebo. Int Clin Psychopharmacol 9: 251-261
28. Harrison C, Subhan Z, Hindmarch I (1985) Residual effects of zopiclone and benzodiazepine hypnotics on psychomotor performance related to car driving. Drugs Exp Clin Res 11: 823-829
29. Hindmarch I, Clyde CA (1980) Effects of triazolam and nitrazepam on sleep quality, morning vigilance and psychomotor performance. Drug Res 30: 1163-1166
30. Hindmarch I, Kern J S (1992) Behavioural toxicity of antidepressants with particular reference to moclobemide. Psychopharmacology 106: 49-55
31. Irving A, Jones W (1992) Methods for testing impairment of driving due to drugs. Eur J Clin Pharmacol 43: 61-66
32. Lader M, Melhuist A, Harris E (1982) Residual effects of repeated doses of 0.5 and 1 mg flunitrazepam. Eur J Clin Pharmacol 23: 135-140
33. Laurell H, Tornros J (1991) Interaction effects of hypnotics and alcohol on driving performance. J Traffic Med 19: 9-13
34. Lavoisy J, Zivkovic B, Benavides J, Perrault G H, Roberts P (1992) Apport du zolpidem dans la prise en charge des troubles du sommeil. L'encéphale 18: 379-392
35. Maes V, Grenez O, Charlier C, Smer H, Verstraete A, Wenning R (1999) Classification of medicines according to their influence on driving ability. Acta Clinica Belgica 1 (Suppl 1): 82-88
36. Mattmann P, Loepfe M, Scheitlin T, Schmidlin D, Gerne M, Strauch I, Lehmann D, Borbely A A (1982) Day-time residual effects and motor activity after three benzodiazepine hypnotics. Drug Res 32: 461-465
37. Menzin J, Lang K M, Levy P, Levy E (2001) A general model of the effects of sleep medications on the risk and cost of motor vehicle accidents and its application to France. Pharmacoeconomics 19: 69-78
38. Mercier-Guyon C (1994) Médicaments, drogues et comportement au volant. Bull Acad Méd 178: 1111-1122
39. Nicholson A N, Pascoe P A (1986) Hypnotics activity of imadazopyridine (zopiclone). Br J Clin Pharmacol 21: 205-211
40. O'Hanlon J F (1988) Are actual driving tests necessary for evaluating drug safety? Int Clin Psychopharmacol 3: 81-85
41. O'Hanlon J F (1995) Zopiclone's residual effects on psychomotor and information processing skills involved in complex tasks such as car driving: a critical review. Eur Psychiatry 10 (Suppl 3): 137S-143S
42. O'Hanlon J F, Volkerts E R (1986) Hypnotics and actual driving performance. Acta Psychiatr Scand 332: 95-104
43. O'Hanlon J F, Haak T W, Blaauw G J, Riemersma J B J (1982) Diazepam impairs lateral position control in highway driving. Science 217: 79-81
44. Owen D H, Warren D (1987) Perception and control of self-motion: implication for visual simulation of vehicular locomotion. In Ergonomics and human factors recent research, pp. 40-70. New York, Springer-Verlag
45. Riedel W J, Vermeeren A, van Boxtel M P J, Vuurman E F P M, Verdhey F R J, Jolles J, Ramaekers J G (1998) Mechanisms of drug-induced driving impairment: a dimentional approach. Hum Psychopharmacol Clin Exp 13: S49-S63
46. Salva P, Costa J (1995) Clinical pharmacokinetics and pharmacodynamics of zolpidem: therapeutic implications. Clin Pharmacokinet 29: 142-153
47. Seppala T, Nuott E, Dreyfust J F (1982) Drug-alcohol interactions on psychomotor skills: zopiclone and flunitrazepam. Int Pharmacopsychiatry 17 (Suppl 2): 127-135
48. Sherwood N (1998) A critical review of drugs and driving. Behav Res Road Safety 8: 49-58
49. Shoptaugh C F, Whitaker L A (1984) Verbal response times to directional traffic signs embedded in photographic street scenes. Human Factors 26: 235-244
50. Tafty M, Besset A, Billiard M (1992) Effects of zopiclone on subjective evaluation of sleep and daytime alertness and on psychomotor and physical performance in athletes. Prog Neuropsychopharmacol Biol Psychiatry 16: 55-63
51. Undén M, Schechter B R (1996) Next day effects after nighttime treatment with zolpidem: a review. Eur Psychiatry 11 (Suppl 1): 21S-30S
52. Van der Hulst M, Rothengatter T, Meijman T (1999) The effects of reduced visibility and time pressure on drivers' distance keeping behaviour. In Gale A G (ed), Brown I D, Haslegrave C M, Taylor S P (co-eds), pp. 311-318. Vision in vehicle VII. Elsevier Science, Amsterdam
53. Vermeeren A, O'Hanlon J F, Declerck A C (1995) Acute effects of zolpidem and flunitrazepam on sleep, memory and driving performance, compared to those of partial sleep deprivation and placebo. Acta Therapeut 21: 47-64
54. Vermeeren A, Danjou P E, O'Hanlon J F (1998) Residual effects of evening and middle-of-the-night administration of zaleplon 10 and 20 mg on memory and actual driving performance. Hum Psychopharmacol 13: S98-S107
55. Vermeeren A, Riedel W J, Van Boxtel M P J, Darwish M, Paty I, Patat A (2002) Differencial residual effects of zaleplon and zopiclone on actual driving: a comparison with a low dose of alcohol. Sleep 25: 224-231
56. Volkerts E R, de Vries G, Wiethoff M, Meijer T, O'Hanlon J F (1983) Loprazolam and flunitrazepam's residual effects upon actual driving performance. Technical report VK-83-04. Traffic Research Center, University of Groningen, Groningen
57. Volkerts E R, Louwerens J W, Gloerich A B M, Brookhuis K J, O'Hanlon J F (1984) Zopiclone's residual effect upon actual driving performance versus those of notrazepam and flunitrazepam. Technical report VK-84-10. Traffic Research Center, University of Groningen, Groningen
58. Volkerts E R, O'Hanlon J F (1986) Hypnotics' residual effects on driving performance. In O'Hanlon J F, De Gier J J (eds), pp. 123-135. Drugs and driving performance. Taylor and Francis, London
59. Welfort A T (1980) Reaction time. Academic Press, New York
60. Wetherell A (1986) Drugs and drivers' visual perception. In Gale A G (ed), Brown I D, Haslegrave C M, Taylor S P (co-eds), pp. 33-42. Vision in vehicle. Elsevier Science, Amsterdam
61. Willumeit H-P, Ott H, Kuschel C H R (1991) Effects of lormetazepam and other benzodiazepine receptor ligands on car-driving-related skills. Human Psychopharmacol 6: 209-218